2021-01-22 | By malaymail | 67 Hits

The vaccine from BioNTech and US partner Pfizer was initially sold in the EU in vials meant to deliver five doses but a global shortage of shots and a viability assessment on dosage convinced the EU drugs regulator to approve on January 8 the extraction of six doses from the same vials Reuters picFRANKFURT Jan 22 BioNTech is to supply 50 million specialty needles at no profit to countries struggling to extract a sixth dose from vials of its Covid19 vaccine while Europes immunisation campaign is hampered by a temporary supply shortfallEuro >>READ MORE